Medical Products, Pharmacy Profession and Pharmaceutical Establishments Law
Medical Products, Pharmacy Profession and Pharmaceutical Establishments Law — Article 36 — Article (36) Drug Policy Committee
Part Two: Regulation and Circulation of Medical Products
Pursuant to this Decree-Law, a committee called the “Pharmaceutical Policy Committee” shall be established, reporting to the President, and shall be responsible for proposing policies related to the circulation, pricing, and monitoring of Medical Products in the State. A decision shall be issued by the Cabinet concerning its formation, jurisdiction, and the determination of its work system, based on a proposal from the Chairman.
Interpretation and application must be checked against the official text and current version.